Hellman & Friedman, JMI Equity to exit Ellucian

TPG Capital and Leonard Green Partners have agreed to buy Ellucian. The sellers are Hellman & Friedman and JMI Equity. Financial terms weren’t announced but Reuters valued the deal at $3.5 billion. Fairfax, Virginia-based Ellucian provides software to universities and colleges. Morgan Stanley & Co. LLC, BofA Merrill Lynch, BMO Capital Markets Corp., and Barclays served as financial advisors to TPG and Leonard Green. Credit Suisse and Goldman, Sachs & Co. served as financial advisors to Ellucian.

Burtson joins CAA as CFO

Creative Artists Agency, a portfolio company of TPG Capital, said Monday that James Burtson is joining as CFO effective July 13. Burtson most recently served as Senior Vice President of Time Warner Inc.


TPG to sell Par Pharma to Endo in $8.05 bln deal

Endo International said Monday it has agreed to buy Par Pharmaceutical Holdings Inc. from TPG Capital in a deal valued at $8.05 billion, including debt. The boards of Endo and Par have both approved the deal. The purchase includes about 18 million Endo shares and $6.5 billion cash to Par shareholders. Deutsche Bank and Barclays are providing financing. TPG acquired Par, a generic drug maker, in 2012 in a $1.9 billion deal. Barclays, Deutsche Bank, and Houlihan Lokey acted as financial advisors to Endo. JP Morgan acted as financial advisor to Par.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget